You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

phosphodiesterase 10 inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in Shibeen Elkom (Roflumilast 250Mcg Tab, Placebo)

Recruiting
  • Major Depressive Disorder
  • Roflumilast 500Mcg Tab
  • Placebo
  • Shibeen Elkom, Menoufia, Egypt
    Faculty of Pharmacy
Jan 16, 2023

Phosphodiesterase Type 5 Inhibitor to Improve Anabolic

Not yet recruiting
  • Sarcopenia
  • Tadalafil 5mg
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jul 25, 2022

Osteoarthritis Trial in Shibin Al Kawm (Cilostazol 50 MG, Placebo)

Recruiting
  • Osteoarthritis
  • Cilostazol 50 MG
  • Placebo
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Pharmacy
Jul 28, 2022

Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)

Active, not recruiting
  • Erectile Dysfunction Following Radiation Therapy
  • +2 more
  • P shot arm ( Autologous Platelet Rich Plasma)
  • PDE5i arm
  • Mansoura, Outside U.S./Canada, Egypt
    Mansoura urology and nephrology center
Mar 15, 2023

MDD Trial in Shibin Al Kawm (Sildenafil Citrate, Placebo oral tablet)

Recruiting
  • Major Depressive Disorder
  • Sildenafil Citrate
  • Placebo oral tablet
  • Shibīn Al Kawm, Egypt
    Faculty of Medicine
Jan 16, 2023

Asthma Trial in Sacramento (Roflumilast, Placebo)

Recruiting
  • Asthma
  • Sacramento, California
    UC Davis
Jan 31, 2022

Erectile Dysfunction, Sexual Dysfunction Trial in Salt Lake City (Natesto Nasal Product, Placebo)

Recruiting
  • Erectile Dysfunction
  • Sexual Dysfunction
  • Natesto Nasal Product
  • Placebo
  • Salt Lake City, Utah
    University of Utah, Division of Urology
Aug 11, 2022

Schizophrenia Trial in Shibin Al Kawm (Placebo oral tablet, Pentoxifylline)

Completed
  • Schizophrenia
  • Shibīn Al Kawm, Egypt
    Faculty of Medicine
Oct 23, 2022

Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    WeiWei Xiao
Nov 3, 2023

Congenital Diaphragmatic Hernia, Pulmonary Hypertension Trial in Salt Lake City (Sildenafil Oral Suspension, Placebo)

Not yet recruiting
  • Congenital Diaphragmatic Hernia
  • Pulmonary Hypertension
  • Sildenafil Oral Suspension
  • Placebo
  • Salt Lake City, Utah
    Primary Children's Hospital
Jan 27, 2022

Rheumatoid Arthritis Trial (Cilostazol, Methotrexate, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Oct 30, 2022

Chronic Sinusitis Trial in Shibin Al Kawm (Roflumilust, Prednisolone)

Not yet recruiting
  • Chronic Sinusitis
  • Shibīn Al Kawm, Menoufia, Egypt
    Menoufia Faculty of Medicine
May 5, 2022

MDD Trial in Shibin Al Kawm (Tadalafil 5Mg Tab, Placebo)

Recruiting
  • Major Depressive Disorder
  • Tadalafil 5Mg Tab
  • Placebo
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Pharmacy
Aug 31, 2021

Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)

Not yet recruiting
  • Chronic Kidney Diseases
  • Placebo
  • Co-Enzyme Q10
  • (no location specified)
Jul 4, 2023

Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)

Not yet recruiting
  • Lupus Nephritis
  • Chronic Kidney Diseases
  • Dapagliflozin 10mg Tab
  • Standard maintenance therapy
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Nov 24, 2023

Alcohol, Phosphodiesterase Inhibitor, Erectile Dysfunction Trial in Shanghai (TPN171H tablet plus alcohol, alcohol, TPN171H

Completed
  • Alcohol
  • +2 more
  • TPN171H tablet plus alcohol
  • +2 more
  • Shanghai, China
    Shanghai Xuhui Central Hospital
May 20, 2022

Chronic Coronary Syndrome, Atrial Fibrillation Trial (Dapagliflozin 10mg Tab, Placebo Tab)

Not yet recruiting
  • Chronic Coronary Syndrome
  • Atrial Fibrillation
  • Dapagliflozin 10mg Tab
  • Placebo Tab
  • (no location specified)
May 9, 2023

Tricuspid Regurgitation Trial in Seoul (Dapagliflozin Propanediol Hydrate 12.3 mg)

Recruiting
  • Tricuspid Regurgitation
  • Dapagliflozin Propanediol Hydrate 12.3 mg
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 9, 2023

Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • +3 more
  • Dapagliflozin 10mg Tab
  • Placebo
  • Moscow, Russian Federation
    National Medical Research Center for Cardiology, Ministry of Hea
Mar 20, 2023

Malignant Ascites Trial (Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy)

Not yet recruiting
  • Malignant Ascites
  • (no location specified)
Aug 11, 2022

Sickle Cell People With Pulmonary Hypertension

Completed
  • Pulmonary Hypertension
  • Sickle Cell Disease
    • Bethesda, Maryland
      National Heart, Lung and Blood Institute (NHLBI)
    Apr 16, 2021

    COPD Exacerbation, Enoximone, Phosphodiesterase Inhibitor Trial in Arnhem (Enoximone)

    Terminated
    • COPD Exacerbation
    • +2 more
    • Arnhem, M, Netherlands
      M.V. Koning
    Dec 23, 2021

    Diabetes, Heart Failure Trial in Singapore (Dapagliflozin 10 MG [Forxiga])

    Completed
    • Diabetes Mellitus
    • Heart Failure
    • Dapagliflozin 10 MG [Forxiga]
    • Singapore, Singapore
      National Heart Centre Singapore
    Jan 13, 2023

    Non Small Cell Lung Cancer Trial (HLX208+HLX10)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • HLX208+HLX10
    • (no location specified)
    Nov 30, 2022

    Discoid Lupus Erythematosus Trial in New York (CC-10004)

    Completed
    Has Results
    • Discoid Lupus Erythematosus
    • New York, New York
      New York University Tisch Hospital
    Feb 10, 2021